Atlas Trials

Use of SPECT-CT for Comparison of Dosimetry Methods in PSMA-targeted Radioligand Therapy (SPECTacular Study)

Clinical trial NCT05823402 · UNKNOWN

Trial details

NCT number
NCT05823402
Sponsor
BAMF Health
Status
UNKNOWN
Phase
Not Applicable
Study type
INTERVENTIONAL
Metastatic Castration-resistant Prostate Cancer
Start date
2023-05-01
Primary completion
2024-10-31
Enrollment
30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.